Our website is made possible by displaying non-intrusive online advertisements to our visitors.
Please consider supporting us by disabling or pausing your ad blocker.
Next few quarters should continue to see decent growth with additional satellite clinic in Jakarta, Indonesia and launching of IVF facility in Philippines
Saliran Group earnings for FY2024–FY2026 are projected to grow by 52.3%, 14.3%, and 14.1%, reaching RM13 million, RM14.8 million, and RM16.9 million, respectively. The compound annual growth rate (CAGR) for revenue is expected to be 10%, with profit margins of 4.9%, 5.0%, and 5.2% over the next three years.